GLENN F TILTON Insider Trading $ABBV AbbVie Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GLENN F TILTON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GLENN F TILTON. GLENN F TILTON is in ABBOTT LABORATORIES ($ABT) and Director in ABBOTT LABORATORIES ($ABT) and Chairman & CEO in United Continental Holdings, Inc. ($UAL) and Chairman, President & CEO in United Continental Holdings, Inc. ($UAL) and Chairman,President & CEO in United Continental Holdings, Inc. ($UAL) and Director in Phillips 66 ($PSX) and Director in AbbVie Inc. ($ABBV).
GLENN F TILTON in AbbVie Inc.
Trading Symbol: ABBVIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GLENN F TILTON: Director
Holdings: 46,168 shares
Current Value: $2,800,089
Latest Transaction: May 11 2021
$ABBV Market Capitalization: $98.42B
$ABBV Previous Close: $60.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GLENN F TILTON in AbbVie Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABT, ABBV, PSX, UAL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 1,681 | 0 | 46,168 | 44.5 K to 46.2 K (+3.78 %) |
May 12 2020 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,333 | 0 | 44,487 | 42.2 K to 44.5 K (+5.53 %) |
May 07 2019 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,419 | 0 | 42,154 | 39.7 K to 42.2 K (+6.09 %) |
Jun 29 2018 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Buy | P | 91.90 | 5,400 | 496,274 | 39,735 | 34.3 K to 39.7 K (+15.73 %) |
May 07 2018 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 1,899 | 0 | 34,335 | 32.4 K to 34.3 K (+5.85 %) |
May 07 2018 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 1,899 | 0 | 34,335 | 32.4 K to 34.3 K (+5.85 %) |
Jan 03 2018 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 387 | 0 | 29,229 | |
Jul 05 2017 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 517 | 0 | 27,970 | |
May 09 2017 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,770 | 0 | 32,436 | 29.7 K to 32.4 K (+9.34 %) |
Apr 04 2017 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 575 | 0 | 27,191 | |
Jan 04 2017 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 598 | 0 | 26,342 | |
Oct 04 2016 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 594 | 0 | 25,512 | |
Jul 15 2016 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 573 | 0 | 24,709 | |
May 10 2016 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,974 | 0 | 29,666 | 26.7 K to 29.7 K (+11.14 %) |
Apr 04 2016 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 603 | 0 | 23,917 | |
Jan 05 2016 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 582 | 0 | 23,067 | |
Oct 02 2015 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 634 | 0 | 22,295 | |
Jul 02 2015 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 513 | 0 | 21,501 | |
May 12 2015 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,187 | 0 | 26,692 | 24.5 K to 26.7 K (+8.92 %) |
Apr 02 2015 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 589 | 0 | 20,827 |
Page: 1